News & Media

For Immediate Release

Periwell Launches Wearable-Driven Symptom Intelligence to Close the Perimenopause Care Gap

NEW YORK, NY — April 2, 2026 — Periwell, a clinical-first health technology company, today announced the official launch of its perimenopause symptom intelligence platform. Designed to address the diagnostic delays and dismissal millions of women face, Periwell combines validated clinical staging systems with real-time wearable data to provide objective health insights.

Perimenopause affects approximately 1.3 billion women worldwide, yet remains one of the most underserved transitions in health. Research shows that up to 1 in 3 women receive an incorrect diagnosis before their perimenopause symptoms are correctly identified.

"We built Periwell because silence and dismissal are not medical treatments," says Elena Rossi, Founder of Periwell. "By translating vague symptoms into objective clinical scores, we are empowering women to walk into their appointments with the data they need to be heard."

The platform integrates directly with Apple Watch, Oura, and Fitbit to analyze sleep, HRV, and body temperature alongside subjective symptom logs using the Greene Climacteric and Menopause Rating Scales (MRS). The result is a clinician-grade Health Report that facilitates faster, more accurate treatment decisions.

About Periwell: Periwell is a women's health technology company dedicated to closing the care gap in perimenopause. Grounded in the STRAW+10 clinical framework, Periwell provides data-driven intelligence to help women and their providers navigate the transition with clarity.